EFDID: 93884EFD: View Filing

Issuer: Cynapsus Therapeutics Inc. (0001532079) - D

Accession: 0001532079-14-000002 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
  • Entity Name:
    Cynapsus Therapeutics Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    CANADA (FEDERAL LEVEL)
  • Year of Inc:
    Over 5 years ago
  • Address:
    828 RICHMOND STREET WEST
    TORONTO, A6 M6J 1C9
  • Persons:
    Related Persons 9
    Anthony Giovinazzo
    Executive OfficerDirector
    Andrew Williams
    Executive Officer
    Tomer Gold
    Director
    Ronald Hosking
    Director
    Nan Hutchinson
    Director
    Perry Molinoff
    Director
    Ilan Oren
    Director
    Alan D. C. Ryley
    Director
    Rochelle Stenzler
    Director
EDGAR: Offering Information
  • Accession Date:
    04/21/2014
  • First Sale Date:
    04/15/2014
  • Offering Amount:
    $42,916,967
  • Amount Sold:
    $14,546,285
  • Amount Remaining:
    $28,370,682
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity, Each unit is comprised of one common share and one share purchase warrant. Each warrant is exercisable for one common share at an exercise price of Cdn$0.81 for a period of 60 months.
  • Sales Clarification:
    The additional $28,370,682 may be received upon the exercise of share purchase warrants sold inside and outside the U.S. U.S. dollar amounts are based on the Bank of Canada noon rate of exchage report on April 15, 2014, which was CN$1.0981=US$1.00.
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Noble Financial Capital Markets 15768 None None CA, FL, IL, NY
Maddie King III 2784584 Brookline Group, LLC 153587 CA, FL, IL, NY
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Cynapsus Therapeutics Inc./s/ Andrew WilliamsAndrew WilliamsChief Financial Officer2014-04-17